ACADIA Pharmaceuticals, Inc. (ACAD)
21.23
-0.01
(-0.05%)
USD |
NASDAQ |
Nov 06, 16:00
21.21
-0.02
(-0.09%)
After-Hours: 20:00
ACADIA Pharmaceuticals Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.529M |
| March 31, 2026 | 66.28M |
| December 31, 2025 | -55.87M |
| September 30, 2025 | -79.35M |
| June 30, 2025 | -43.29M |
| March 31, 2025 | -124.05M |
| December 31, 2024 | 122.15M |
| September 30, 2024 | -82.46M |
| June 30, 2024 | -56.19M |
| March 31, 2024 | -14.04M |
| December 31, 2023 | -0.347M |
| September 30, 2023 | 34.11M |
| June 30, 2023 | -194.28M |
| March 31, 2023 | 192.52M |
| December 31, 2022 | -17.75M |
| September 30, 2022 | 15.44M |
| June 30, 2022 | -55.80M |
| March 31, 2022 | 131.34M |
| December 31, 2021 | 71.55M |
| September 30, 2021 | -156.32M |
| June 30, 2021 | -17.21M |
| March 31, 2021 | 30.88M |
| December 31, 2020 | -116.96M |
| September 30, 2020 | 152.99M |
| June 30, 2020 | 126.86M |
| Date | Value |
|---|---|
| March 31, 2020 | 29.61M |
| December 31, 2019 | -209.14M |
| September 30, 2019 | 9.923M |
| June 30, 2019 | 10.63M |
| March 31, 2019 | 22.76M |
| December 31, 2018 | -188.95M |
| September 30, 2018 | 31.78M |
| June 30, 2018 | -3.942M |
| March 31, 2018 | 89.62M |
| December 31, 2017 | -18.09M |
| September 30, 2017 | 19.33M |
| June 30, 2017 | 38.30M |
| March 31, 2017 | 52.94M |
| December 31, 2016 | 69.14M |
| September 30, 2016 | -154.91M |
| June 30, 2016 | -7.46M |
| March 31, 2016 | -168.70M |
| December 31, 2015 | 56.35M |
| September 30, 2015 | 8.308M |
| June 30, 2015 | 44.06M |
| March 31, 2015 | 38.47M |
| December 31, 2014 | 40.48M |
| September 30, 2014 | 38.87M |
| June 30, 2014 | -67.51M |
| March 31, 2014 | -99.11M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 23.50M |
| Arcturus Therapeutics Holdings, Inc. | 0.0193M |
| ADMA Biologics, Inc. | -2.068M |
| Immunic, Inc. | -0.249M |
| Viking Therapeutics, Inc. | 92.52M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow Yield | 3.96% |